Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis.
Puzanov I, Subramanian P, Yatsynovich YV, Jacobs DM, Chilbert MR, Sharma UC, Ito F, Feuerstein SG, Stefanovic F, Switzer B, Hicar MD, Curtis AB, Spangenthal EJ, Dy GK, Ernstoff MS, Vachhani P, Page BJ, Agrawal N, Khunger A, Kapoor A, Hattoum A, Schentag JJ.
Puzanov I, et al. Among authors: khunger a.
J Immunother Cancer. 2021 Jun;9(6):e002553. doi: 10.1136/jitc-2021-002553.
J Immunother Cancer. 2021.
PMID: 34162715
Free PMC article.